Drug Shortage Report for LORAZEPAM INJECTION USP
Report ID | 30518 |
Drug Identification Number | 02388669 |
Brand name | LORAZEPAM INJECTION USP |
Common or Proper name | LORAZEPAM |
Company Name | PFIZER CANADA ULC |
Market Status | DORMANT |
Active Ingredient(s) | LORAZEPAM |
Strength(s) | 4MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10x1mL GVL |
ATC code | N05BA |
ATC description | ANXIOLYTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2017-12-15 |
Estimated end date | |
Actual end date | 2018-01-05 |
Shortage status | Resolved |
Updated date | 2018-02-07 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-23 | English | Compare |
v2 | 2017-11-23 | English | Compare |
v3 | 2017-11-23 | French | Compare |
v4 | 2017-12-12 | English | Compare |
v5 | 2017-12-14 | English | Compare |
v6 | 2017-12-14 | French | Compare |
v7 | 2017-12-16 | English | Compare |
v8 | 2018-02-07 | English | Compare |
v9 | 2018-02-07 | French | Compare |
Showing 1 to 9 of 9